Research programme: anti-alpha folate receptor monoclonal antibody - DompeAlternative Names: AFRA; Anti-α-FR Mab; FabOvar
Latest Information Update: 29 Jun 2016
At a glance
- Originator Dompe Farmaceutici
- Developer Advanced Accelerator Applications; Dompe Farmaceutici
- Class Monoclonal antibodies
- Mechanism of Action Folate receptor 1 antagonists; Ionising radiation emitters
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Ovarian cancer